Regional Blood Flow Responses to Acute ANG II Infusion: Effects of Nitric Oxide Synthase Inhibition
- 1 July 1999
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 34 (1) , 116-123
- https://doi.org/10.1097/00005344-199907000-00019
Abstract
We hypothesized that nitric oxide (NO) opposes regional vasoconstriction caused by acute angiotensin II (ANG II) infusion in conscious rats. Mean arterial pressure (MAP), blood flow, and vascular conductance (regional blood flow/MAP; ml/min/100 g/mm Hg) were measured and/or calculated before and at 2 min of ANG II infusion (0.05 or 1 μg/kg/min, i.a.) in the absence and presence of NO synthase (NOS) inhibition [N G-nitro-L-arginine methyl ester (L-NAME), 0.25 or 1 mg/kg, i.a.]. ANG II reduced stomach and hindlimb conductance only after NOS inhibition. For example, whereas 0.05 μg/kg/min ANG II did not attenuate conductance in the stomach (i.e., 1.04 ± 0.08 to 0.93 ± 0.12 ml/min/100 g/mm Hg), this variable was reduced (i.e., 0.57 ± 0.14 to 0.34 ± 0.05 ml/min/100 g/mm Hg; p < 0.05) when ANG II was infused after 0.25 mg/kg L-NAME. In addition, whereas hindlimb conductance was similar before and after administering 1 μg/kg/min ANG II (i.e., 0.13 ± 0.01 and 0.09 ± 0.02, respectively), this variable was reduced (i.e., 0.07 ± 0.01 and 0.02 ± 0.00, respectively; p < 0.05) when ANG II was infused after 1 mg/kg L-NAME. These findings indicate that NO opposes ANG II-induced vasoconstriction in the stomach and hindlimb. In contrast, whereas both doses of ANG II decreased (p < 0.05) vascular conductance in the kidneys and small and large intestine regardless of whether NOS inhibition was present, absolute vascular conductance was lower (p < 0.05) after L-NAME. For example, 1 μg/kg ANG II reduced renal conductance from 3.34 ± 0.31 to 1.22 ± 0.14 (p < 0.05). After 1 mg/kg L-NAME, renal conductance decreased from 1.39 ± 0.18 to 0.72 ± 0.16 (p < 0.05) during ANG II administration. Therefore the constrictor effects of NOS inhibition and ANG II are additive in these circulations. Taken together, our results indicate that the ability of NO to oppose ANG II-induced constriction is not homogeneous among regional circulations.Keywords
This publication has 12 references indexed in Scilit:
- Angiotensin II Stimulates Synthesis of Endothelial Nitric Oxide SynthaseHypertension, 1998
- Effects of Angiotensin II Receptor Blockade During Exercise: Comparison of Losartan and SaralasinJournal of Cardiovascular Pharmacology, 1996
- Role of Nitric Oxide in Short-term and Prolonged Effects of Angiotensin II on Renal HemodynamicsHypertension, 1996
- Modulation by nitric oxide and prostaglandin of the renal vascular response to angiotensin II (3–8)British Journal of Pharmacology, 1996
- Effects of NO synthase inhibition on the muscular blood flow response to treadmill exercise in ratsJournal of Applied Physiology, 1994
- Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivoBritish Journal of Pharmacology, 1990
- Regional and cardiac haemodynamic effects of NG‐nitro‐l‐arginine methyl ester in conscious, Long Evans ratsBritish Journal of Pharmacology, 1990
- Regional haemodynamic effects of neuropeptide Y, vasopressin and angiotensin II in conscious, unrestrained, Long Evans and Brattleboro ratsJournal of the Autonomic Nervous System, 1988
- Multiple simultaneous determinations of hemodynamics and flow distribution in conscious ratJournal of Pharmacological Methods, 1984
- Blood flow measurements with radionuclide-labeled particlesProgress in Cardiovascular Diseases, 1977